Cargando…
“Suffocating” tumors by blocking adaptation to hypoxia: a new headway in melanoma immunotherapy
We recently reported that inhibiting Hypoxia-inducible Factor-1α (Hif1a) transcriptional activity improves melanoma immunotherapy by driving immune cells into the tumor microenvironment (TME). This Author’s View provides additional perspectives on how hypoxia inhibitors combined with immunotherapy c...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Taylor & Francis
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8437449/ https://www.ncbi.nlm.nih.gov/pubmed/34527430 http://dx.doi.org/10.1080/2162402X.2021.1968611 |